Cefalotin: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)
Gerald Chi (talk | contribs)
mNo edit summary
Line 19: Line 19:
| routes_of_administration = [[Intravenous therapy|IV]]
| routes_of_administration = [[Intravenous therapy|IV]]
}}
}}
{{SI}}
__NOTOC__
 
{{CMG}}


==Overview==
==Overview==

Revision as of 19:10, 4 April 2015

Cefalotin
Clinical data
Pregnancy
category
  • AU: A
Routes of
administration
IV
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • UK: POM (Prescription only)
Pharmacokinetic data
Bioavailabilityn/a
Protein binding65 to 80%
MetabolismHepatic
Elimination half-life30 minutes to 1 hour
ExcretionRenal
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H16N2O6S2
Molar mass396.44 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cefalotin (INN) (Template:PronEng) or cephalothin (USAN) (Template:IPA) is a first-generation cephalosporin antibiotic. It was the first cephalosporin marketed and continues to be widely used. It is an intravenously-administered agent with a similar antimicrobial spectrum to cefazolin and the oral agent cefalexin. Cefalotin sodium is commonly marketed under the trade name Keflin (Lilly).

See also

Template:WH Template:WS